2022
DOI: 10.1016/j.coms.2021.12.001
|View full text |Cite
|
Sign up to set email alerts
|

Classification and Staging of Melanoma in the Head and Neck

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(15 citation statements)
references
References 53 publications
0
12
0
Order By: Relevance
“…In the TNM system, the 'M' assesses dissemination to distal lymph nodes and organs, with the brain, lungs and liver being the preferred metastatic sites. 6,19 Melanoma staging may further be classified into stages 0-IV. 5 Stage 0, also known as in situ, denotes cancer cells that are confined to the epidermis lacking infiltration into the dermis, lymph nodes or distant organs.…”
Section: Melanoma Diagnosis and Stagingmentioning
confidence: 99%
See 3 more Smart Citations
“…In the TNM system, the 'M' assesses dissemination to distal lymph nodes and organs, with the brain, lungs and liver being the preferred metastatic sites. 6,19 Melanoma staging may further be classified into stages 0-IV. 5 Stage 0, also known as in situ, denotes cancer cells that are confined to the epidermis lacking infiltration into the dermis, lymph nodes or distant organs.…”
Section: Melanoma Diagnosis and Stagingmentioning
confidence: 99%
“…Tumour thickness, within the TNM framework, is characterised by the primary tumour's thickness and ulceration. Conversely, the Breslow measurement considers the depth of invasion of the neoplasm 6,19 . Nodal involvement signifies whether the tumour has progressed to proximal lymph nodes.…”
Section: Melanoma Diagnosis and Stagingmentioning
confidence: 99%
See 2 more Smart Citations
“…The traditional clinicopathologic classification of melanoma is based on morphologic aspects of the growth stage, and the World Health Organization defines and distinguishes the four most common subtypes: superficial spreading melanoma (30% to 60%), lentigo maligna melanoma (10% to 40%), nodular melanoma (15% to 35%), and acral lentiginous melanoma (5% to 10%). 33 Recurrence and metastasis rates are also usually increased in cases involving the eyelid margin, conjunctiva, fornix, fossa, and caruncle. [34][35][36] The most influential factor in the pathogenesis of eyelid melanoma is UVB, especially UVB (290 to 320 nm).…”
Section: Melanomamentioning
confidence: 99%